103 related articles for article (PubMed ID: 11130021)
1. Efficacy of PSA in the detection of carcinoma of the prostate in patients presenting with acute urinary retention.
McNeill SA; Hargreave TB
J R Coll Surg Edinb; 2000 Aug; 45(4):227-30. PubMed ID: 11130021
[TBL] [Abstract][Full Text] [Related]
2. The effect of antibiotics on elevated serum prostate specific antigen in patients with urinary symptoms and negative digital rectal examination: a pilot study.
Bulbul MA; Wazzan W; Hijaz A; Shaar A
J Med Liban; 2002; 50(1-2):23-5. PubMed ID: 12841309
[TBL] [Abstract][Full Text] [Related]
3. Relation between acute urinary retention, chronic prostatic inflammation and accompanying elevated prostate-specific antigen.
Kefi A; Koseoglu H; Celebi I; Yorukoglu K; Esen A
Scand J Urol Nephrol; 2006; 40(2):155-60. PubMed ID: 16608815
[TBL] [Abstract][Full Text] [Related]
4. [The effect of acute urinary retention on serum prostate specific antigen concentration].
Hua LX; Wu HF; Sui YG; Cheng SG; Xu ZQ
Zhonghua Nan Ke Xue; 2002; 8(2):134-5. PubMed ID: 12479031
[TBL] [Abstract][Full Text] [Related]
5. Detection of prostatic carcinoma: the role of TRUS, TRUS guided biopsy, digital rectal examination, PSA and PSA density.
Men S; Cakar B; Conkbayir I; Hekimoglu B
J Exp Clin Cancer Res; 2001 Dec; 20(4):473-80. PubMed ID: 11876539
[TBL] [Abstract][Full Text] [Related]
6. Management outcome of acute urinary retention: model of prediction.
Daly P; Connolly S; Rogers E; Sweeney P
Urol Int; 2009; 83(1):39-43. PubMed ID: 19641357
[TBL] [Abstract][Full Text] [Related]
7. Role of digital rectal examination and prostate specific antigen in detecting carcinoma prostate.
Iqbal N; Bhatti AN; Husain S
J Coll Physicians Surg Pak; 2003 Jun; 13(6):340-2. PubMed ID: 12814533
[TBL] [Abstract][Full Text] [Related]
8. Bladder catheterization and a plasma prostate-specific antigen in patients with benign prostatic hyperplasia and complete urine retention.
Dutkiewicz S; Stepień K; Witeska A
Mater Med Pol; 1995; 27(2):71-3. PubMed ID: 8935194
[TBL] [Abstract][Full Text] [Related]
9. Role of transperineal six-core prostate biopsy in patients with prostate-specific antigen level greater than 10 ng/mL and abnormal digital rectal examination findings.
Luciani LG; De Giorgi G; Valotto C; Zanin M; Bierti S; Zattoni F
Urology; 2006 Mar; 67(3):555-8. PubMed ID: 16527579
[TBL] [Abstract][Full Text] [Related]
10. Biopsy indication--a predictor of pathologic stage among men with preoperative serum PSA levels of 4.0 ng/mL or less and T1c disease.
Freedland SJ; Mangold LA; Epstein JI; Partin AW
Urology; 2004 May; 63(5):887-91. PubMed ID: 15134972
[TBL] [Abstract][Full Text] [Related]
11. [Predictive value of prostate specific antigen density in the detection of prostate cancer in patients with elevated prostate specific antigen levels and normal digital rectal findings or stage A prostate cancer].
Iwaki H; Kajita Y; Shimizu Y; Yamauchi T
Hinyokika Kiyo; 2001 Mar; 47(3):169-74. PubMed ID: 11329957
[TBL] [Abstract][Full Text] [Related]
12. Comparison of 6- and 12-core prostate biopsy in Taiwanese men: impact of total prostate-specific antigen, prostate-specific antigen density and prostate volume on prostate cancer detection.
Chiang IN; Chang SJ; Pu YS; Huang KH; Yu HJ; Huang CY
Urol Int; 2009; 82(3):270-5. PubMed ID: 19440012
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer in patients with an abnormal digital rectal examination and serum prostate-specific antigen less than 4.0 ng/mL.
Bozeman CB; Carver BS; Caldito G; Venable DD; Eastham JA
Urology; 2005 Oct; 66(4):803-7. PubMed ID: 16230142
[TBL] [Abstract][Full Text] [Related]
14. Do prostatic infarction, prostatic inflammation and prostate morphology play a role in acute urinary retention?
Tuncel A; Uzun B; Eruyar T; Karabulut E; Seckin S; Atan A
Eur Urol; 2005 Aug; 48(2):277-83; discussion 283-4. PubMed ID: 15964132
[TBL] [Abstract][Full Text] [Related]
15. Long-term clinical outcome of diagnostic transurethral resection of the prostate in patients with elevated prostate-specific antigen level and minor lower urinary tract symptoms.
van Renterghem K; van Koeveringe G; Achten R; van Kerrebroeck P
Urol Int; 2009; 83(1):60-5. PubMed ID: 19641361
[TBL] [Abstract][Full Text] [Related]
16. Percent free prostate specific antigen in the total prostate specific antigen 2 to 4 ng./ml. range does not substantially increase the number of biopsies needed to detect clinically significant prostate cancer compared to the 4 to 10 ng./ml. range.
Haese A; Dworschack RT; Partin AW
J Urol; 2002 Aug; 168(2):504-8. PubMed ID: 12131298
[TBL] [Abstract][Full Text] [Related]
17. Postoperative PSA and PSA velocity identify presence of prostate cancer after various surgical interventions for benign prostatic hyperplasia.
Helfand BT; Anderson CB; Fought A; Kim DY; Vyas A; McVary KT
Urology; 2009 Jul; 74(1):177-83. PubMed ID: 19428074
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer screening within a prostate specific antigen range of 3 to 3.9 ng./ml.: a comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests.
Mäkinen T; Tammela TL; Hakama M; Stenman UH; Rannikko S; Aro J; Juusela H; Määttänen L; Auvinen A
J Urol; 2001 Oct; 166(4):1339-42. PubMed ID: 11547069
[TBL] [Abstract][Full Text] [Related]
19. High-intensity focused ultrasound therapy for clinically localized prostate cancer.
Lee HM; Hong JH; Choi HY
Prostate Cancer Prostatic Dis; 2006; 9(4):439-43. PubMed ID: 16847468
[TBL] [Abstract][Full Text] [Related]
20. Altered prostate specific antigen reference range after transurethral resection of the prostate.
Wolff JM; Boekels O; Borchers H; Jakse G; Rohde D
Anticancer Res; 2000; 20(6D):4977-80. PubMed ID: 11326651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
